Catalent | CTLT - Nettoeinkommen



Nettoeinkommen Veränderung Datum
Agilent USD 339M 34M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Bruker USD 3.5M 22.5M 2026-03
Centene USD 1.54B 2.64B 2026-03
Charles River Laboratories USD -14.84M 261.71M 2026-03
Cigna USD 1.65B 420M 2026-03
Danaher USD 1.03B 168M 2026-03
Dentsply International USD -10M 136M 2026-03
Elevance Health USD 1.76B 1.22B 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Glaxosmithkline GBP 846.06M 1.87B 2025-12
Humana USD 1.19B 1.98B 2026-03
Illumina USD 134M 200M 2026-03
Intuitive Surgical USD 821.5M 26.7M 2026-03
IQVIA Holdings USD 274M 240M 2026-03
J&J USD 5.24B 119M 2026-03
Laboratory Of America USD 277.8M 113.1M 2026-03
Lonza CHF 426M 119M 2025-06
McKesson USD 1.68B 496M 2026-03
Merck EUR 659M 340M 2026-03
Merck USD -4.24B 7.2B 2026-03
Mettler Toledo International USD 169.45M 116.31M 2026-03
Novartis USD 3.16B 747M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Quest Diagnostics USD 251M 6M 2026-03
Repligen USD 8.33M 4.95M 2026-03
Revvity USD 40.72M 57.65M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
Thermo Fisher Scientific USD 1.65B 313M 2026-03
UnitedHealth USD 6.28B 6.27B 2026-03
Veradigm USD -59.82M 74.35M 2022-12
Waters USD -72M 297.21M 2026-03
West Pharmaceutical Services USD 138.8M 6.7M 2026-03